Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Assets Average: 2016-2025

Historic Assets Average for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $485.5 million.

  • Organogenesis Holdings' Assets Average rose 9.16% to $485.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $485.5 million, marking a year-over-year increase of 9.16%. This contributed to the annual value of $479.0 million for FY2024, which is 5.34% up from last year.
  • Per Organogenesis Holdings' latest filing, its Assets Average stood at $485.5 million for Q3 2025, which was up 4.57% from $464.3 million recorded in Q2 2025.
  • Organogenesis Holdings' Assets Average's 5-year high stood at $485.5 million during Q3 2025, with a 5-year trough of $304.7 million in Q1 2021.
  • In the last 3 years, Organogenesis Holdings' Assets Average had a median value of $459.3 million in 2024 and averaged $461.2 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Assets Average soared by 58.83% in 2021, and later fell by 2.57% in 2024.
  • Organogenesis Holdings' Assets Average (Quarterly) stood at $406.8 million in 2021, then grew by 11.42% to $453.3 million in 2022, then climbed by 1.77% to $461.3 million in 2023, then increased by 2.33% to $472.1 million in 2024, then grew by 9.16% to $485.5 million in 2025.
  • Its Assets Average stands at $485.5 million for Q3 2025, versus $464.3 million for Q2 2025 and $482.6 million for Q1 2025.